PRIME Education’s Post

Tune in and view simpler, safer, more effective treatments for HCV | Simplified Hepatitis C Treatment Strategies | 0.5-hour CME/CE | Hepatitis Accelerator Hub Video #3 of 5 | #MedEd #cme #HepatitisCtreatment | https://bit.ly/3RvsdP2

During this short video, two lives will be lost to Hepatitis C-related illness - but together, we can change this. Hepatitis C is curable, and early testing is the key to saving lives. At WithYou, we’ve been working tirelessly to make testing and treatment more accessible. Over the past year, we’ve: ✅ Completed 12,592 dry blood spot tests ✅ Increased testing by 87% compared to last year ✅ Supported 370 people to start life-saving Hepatitis C treatment Thanks to our work as part of the Gilead Sciences Hep C Drug Treatment Service Provider Forum, a network of peer organisations sharing best practices, we’ve achieved micro-elimination in five of our services—bringing us closer to NHS England’s goal of eliminating Hepatitis C by 2025. The closer we get, the harder it becomes—but it’s achievable. Let’s work together to eliminate Hepatitis C for good. #HepCElimination #EuroTestWeek #HarmReduction #HealthMatters

Hepatitis B surface antigen (HBsAg) is the first marker to appear in the blood in acute hepatitis B, being detected 1 week to 2 months after exposure and 2 weeks to 2 months before the onset of symptoms. Three weeks after the onset of acute hepatitis almost half of all patients will still test positive for HBsAg. #IVD #artron #rapidtest #testkit #qualitativetest #diagnosticpanel #HBV #HepatitisBviruse #HepatitisB #HBsAg

Exciting advancements in the fight against Hepatitis C with an externalized, nurse-led model for HCV micro-elimination! Inspired by the recent findings detailed in the article "Externalised nurse-led model for hepatitis C virus microelimination" published on PubMed, we now have evidence that a patient-centred, nurse-driven approach can successfully administer HCV treatment to people who inject drugs

It's World Hepatitis Testing Week! Did you know that millions of people worldwide are living with hepatitis without even knowing it? This #HepTestWeek, let's change that together. At Cepheid, we're proud to partner with the World Hepatitis Alliance to raise awareness about the importance of hepatitis testing. Our innovative diagnostic solutions are bringing testing to patients when and where they need it most. We kicked off the week with an insightful panel discussion at #TLM24, exploring the latest advancements in hepatitis diagnostics. #HepTestWeek #DiagnosticInnovation #ABetterWay Let's work towards eliminating hepatitis. #HealthcareTechnology #CepheidLive #HCV #HepCantWait Learn more about our innovative diagnostics solutions. Visit cepheid.com

Our team was thrilled to host a panel discussion on the critical role of patient perspectives in Hepatitis B research at the 2024 International Hepatitis B Meeting in Chicago today! 🌟 The diverse panel of experts discussed perspectives across the Hepatitis B research community, focusing on how patient insights drive innovation, improve trial design and shape research priorities in the fight against Hepatitis B. We look forward to sharing diverse perspectives on how patients will shape the future of Hepatitis B research and ways to better collaborate with patients at every stage. Together, let's embrace a patient-guided approach to accelerate finding better treatments and a cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst

In CID, Wesley H. Self, MD, MPH, and colleagues evaluate the prevalence of pneumococcal serotypes among adults hospitalized with community-acquired pneumonia (CAP). https://lnkd.in/eEhB7BDp

Our team was thrilled to host a panel discussion on the critical role of patient perspectives in Hepatitis B research at the 2024 International Hepatitis B Meeting in Chicago today! 🌟 The diverse panel of experts discussed perspectives across the Hepatitis B research community, focusing on how patient insights drive innovation, improve trial design and shape research priorities in the fight against Hepatitis B. We look forward to sharing diverse perspectives on how patients will shape the future of Hepatitis B research and ways to better collaborate with patients at every stage. Together, let's embrace a patient-guided approach to accelerate finding better treatments and a cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst

Our team was thrilled to host a panel discussion on the critical role of patient perspectives in Hepatitis B research at the 2024 International Hepatitis B Meeting in Chicago today! 🌟 The diverse panel of experts discussed perspectives across the Hepatitis B research community, focusing on how patient insights drive innovation, improve trial design and shape research priorities in the fight against Hepatitis B. We look forward to sharing diverse perspectives on how patients will shape the future of Hepatitis B research and ways to better collaborate with patients at every stage. Together, let's embrace a patient-guided approach to accelerate finding better treatments and a cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst

Our team was thrilled to host a panel discussion on the critical role of patient perspectives in Hepatitis B research at the 2024 International Hepatitis B Meeting in Chicago today! 🌟 The diverse panel of experts discussed perspectives across the Hepatitis B research community, focusing on how patient insights drive innovation, improve trial design and shape research priorities in the fight against Hepatitis B. We look forward to sharing diverse perspectives on how patients will shape the future of Hepatitis B research and ways to better collaborate with patients at every stage. Together, let's embrace a patient-guided approach to accelerate finding better treatments and a cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst